| RS179363867 |
IKBKG
|
Health Risk |
Likely pathogenic |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS179363869 |
IKBKG
|
Health Risk |
Likely pathogenic |
— |
| RS179363873 |
ITGB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS179363875 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363876 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363877 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363878 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363879 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363880 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363882 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363883 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363884 |
AIRE
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyglandular autoimmune syndrome, type 1 |
| RS179363885 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363886 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363889 |
AIRE
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363890 |
CYBA
|
Health Risk |
Pathogenic |
— |
| RS179363892 |
CYBA
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS179363894 |
CYBA
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS179363897 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 5 |
| RS179363900 |
MECP2
|
Health Risk |
Likely pathogenic |
Rett syndrome, zappella variant |
| RS179363901 |
MECP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Rett syndrome, Severe neonatal-onset encephalopathy with microcephaly |
| RS1793689014 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1793713030 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1793719203 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1793751061 |
SMO
|
Health Risk |
Likely pathogenic |
Congenital hypothalamic hamartoma syndrome, Congenital hypothalamic hamartoma syndrome |
| RS1793814652 |
SMO
|
Health Risk |
Pathogenic |
Congenital hypothalamic hamartoma syndrome, Congenital hypothalamic hamartoma syndrome |
| RS1793940326 |
SLC26A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1793956441 |
TSPAN12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1793956510 |
TSPAN12
|
Health Risk |
Likely pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS1793999476 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia type II, Citrullinemia |
| RS1794000888 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrullinemia, type II |
| RS1794001446 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS1794039778 |
IFT56
|
Health Risk |
Likely pathogenic |
Caroli disease, Biliary |
| RS1794042527 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS1794042593 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome, Coffin-Siris syndrome 1 |
| RS1794053879 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794059063 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS1794071513 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1794096639 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1794099468 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1794104889 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1794108907 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1794129841 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS1794219866 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1794241080 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS1794247110 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS1794272939 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1794274425 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794276185 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794278792 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1794283740 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794303992 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS1794304689 |
SLC26A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS1794308770 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1794443522 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1794454006 |
ARPC1B
|
Health Risk |
Pathogenic |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease |
| RS1794456297 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome, Coffin-Siris syndrome 1 |
| RS1794468027 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1794472287 |
ELN
|
Health Risk |
Pathogenic |
— |
| RS1794473050 |
EYA4
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 10, Autosomal dominant nonsyndromic hearing loss 10 |
| RS1794475164 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1794490994 |
ARID1B
|
Health Risk |
Pathogenic/Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794509686 |
ARID1B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1794516424 |
ARPC1B
|
Health Risk |
Pathogenic |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease |
| RS1794524337 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1794536022 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS1794540164 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrullinemia type II |
| RS1794541339 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, SLC25A13-related disorder |
| RS1794549840 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794550318 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794553748 |
ARPC1B
|
Health Risk |
Pathogenic |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease |
| RS1794555916 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS1794557198 |
ARID1B
|
Health Risk |
Pathogenic |
— |
| RS1794559320 |
ARPC1B
|
Health Risk |
Likely pathogenic |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease |
| RS1794563443 |
ARID1B
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1794569741 |
ARID1B
|
Health Risk |
Pathogenic |
Rare genetic intellectual disability, Rare genetic intellectual disability |
| RS1794570475 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794574986 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS1794575659 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Inflammatory skin and bowel disease |
| RS1794583960 |
ARID1B
|
Health Risk |
Likely pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794584714 |
ARID1B
|
Health Risk |
Pathogenic |
Coffin-Siris syndrome 1, Coffin-Siris syndrome 1 |
| RS1794602270 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1794603796 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1794604371 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1794611030 |
ARPC1B
|
Health Risk |
Pathogenic/Likely pathogenic |
ARPC1B-related disorder, ARPC1B-related disorder |
| RS1794651890 |
POT1
|
Health Risk |
Pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1794675671 |
ARPC1B
|
Health Risk |
Likely pathogenic |
— |
| RS1794702760 |
POT1
|
Health Risk |
Likely pathogenic |
Tumor predisposition syndrome 3, Tumor predisposition syndrome 3 |
| RS1794703569 |
POT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1794705540 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1794705650 |
POT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumor predisposition syndrome 3, Hereditary cancer-predisposing syndrome |
| RS1794766796 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Autosomal recessive nonsyndromic hearing loss 97 |
| RS1794768738 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS1794774221 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrullinemia, type II |
| RS1794789052 |
VARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS1794834161 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS1794834628 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Hereditary cancer-predisposing syndrome |
| RS1794836064 |
MET
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1794836188 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type II, Citrin deficiency |
| RS1794867368 |
CUX1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |